Showing results (311-320 of 337) with videos related to
Sort By:
Pageof 34
Cancer|February 17, 2001
A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.Radiation Research|September 20, 2016
Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent MetabolismSamuel N Rodman, Jacquelyn M Spence, Tyler J Ronnfeldt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imagingJoseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matterAlexander M Spence, Mark Muzi, David A Mankoff, et al.Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failureJames G Douglas, Keith J Stelzer, David A Mankoff, et al.Neuro-Oncology|April 17, 2001
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium studyS C Schold, J G Kuhn, S M Chang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapyMichael S Bobola, Mary J Emond, A Blank, et al.Cancer|April 2, 2011
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomasWilliam T Couldwell, Amy A Surnock, Alfonso J Tobia, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constantA M Spence, M Muzi, M M Graham, et al.Pageof 34